-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Misses Q3 EPS by 10c
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) PT Lowered to $180 at H.C. Wainwright
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Misses Q4 EPS by 58c
-
-
-
-
-
-
-
Wells Fargo Offers 10 High-Conviction Long/Short Ideas for Q4, Comments on tesla (TSLA): 'We see declining delivery growth'
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Misses Q1 EPS by 22c
-
-
-
-
-
-
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
-
-
-
-
-
-
-
Axsome Therapeutics (AXSM) Tops Q1 EPS by $1.03; Offers Operational Guidance
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

